Compare SMTI & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTI | IBEX |
|---|---|---|
| Founded | 1982 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.2M | 576.0M |
| IPO Year | 2008 | 2017 |
| Metric | SMTI | IBEX |
|---|---|---|
| Price | $34.85 | $44.06 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 166.9K | 151.8K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.63 |
| EPS | N/A | ★ 3.13 |
| Revenue | $15,586,976.00 | ★ $644,076,000.00 |
| Revenue This Year | $13.07 | $10.59 |
| Revenue Next Year | $14.23 | $6.75 |
| P/E Ratio | ★ N/A | $14.15 |
| Revenue Growth | ★ 32.47 | 15.37 |
| 52 Week Low | $16.05 | $25.94 |
| 52 Week High | $35.34 | $45.28 |
| Indicator | SMTI | IBEX |
|---|---|---|
| Relative Strength Index (RSI) | 64.96 | 68.79 |
| Support Level | $33.99 | $36.51 |
| Resistance Level | $35.34 | N/A |
| Average True Range (ATR) | 0.20 | 1.51 |
| MACD | -0.16 | 0.18 |
| Stochastic Oscillator | 50.79 | 80.50 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
IBEX Ltd delivers business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. The company's services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital), and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare, among others, and derives maximum revenue from the United States.